HEADER HYDROLASE 02-FEB-17 5N0F TITLE THE CATALYTIC DOMAIN, BCGH76, OF BACILLUS CIRCULANS AMAN6 IN COMPLEX TITLE 2 WITH 1,6-MANSIFG COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-1,6-MANNANASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS CIRCULANS; SOURCE 3 ORGANISM_TAXID: 1397; SOURCE 4 GENE: AMAN6; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS GLYCOSIDE HYDROLASE, COMPLEX, MANNANASE, S-LINKED POLYSACCHARIDE, KEYWDS 2 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.JIN,S.WILLIAMS,G.DAVIES REVDAT 5 17-JAN-24 5N0F 1 HETSYN REVDAT 4 29-JUL-20 5N0F 1 COMPND REMARK HETNAM SITE REVDAT 4 2 1 ATOM REVDAT 3 23-AUG-17 5N0F 1 JRNL REVDAT 2 16-AUG-17 5N0F 1 JRNL REVDAT 1 09-AUG-17 5N0F 0 JRNL AUTH T.BELZ,Y.JIN,J.COINES,C.ROVIRA,G.J.DAVIES,S.J.WILLIAMS JRNL TITL AN ATYPICAL INTERACTION EXPLAINS THE HIGH-AFFINITY OF A JRNL TITL 2 NON-HYDROLYZABLE S-LINKED 1,6-ALPHA-MANNANASE INHIBITOR. JRNL REF CHEM. COMMUN. (CAMB.) V. 53 9238 2017 JRNL REFN ESSN 1364-548X JRNL PMID 28766587 JRNL DOI 10.1039/C7CC04977C REMARK 2 REMARK 2 RESOLUTION. 1.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 80510 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.156 REMARK 3 R VALUE (WORKING SET) : 0.152 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4223 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.69 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.73 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5995 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.83 REMARK 3 BIN R VALUE (WORKING SET) : 0.1930 REMARK 3 BIN FREE R VALUE SET COUNT : 328 REMARK 3 BIN FREE R VALUE : 0.3010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5412 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 559 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.36 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.12000 REMARK 3 B22 (A**2) : -1.64000 REMARK 3 B33 (A**2) : 0.53000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.127 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.103 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.084 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.011 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.972 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.949 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5677 ; 0.016 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4772 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7737 ; 1.467 ; 1.901 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11112 ; 1.025 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 686 ; 5.404 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 311 ;37.711 ;25.177 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 858 ;11.433 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;23.801 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 788 ; 0.097 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6478 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1241 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2711 ; 3.144 ; 2.452 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2712 ; 3.143 ; 2.452 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3387 ; 3.761 ; 3.684 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3388 ; 3.761 ; 3.684 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2966 ; 4.057 ; 2.747 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2967 ; 4.057 ; 2.747 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 4344 ; 4.671 ; 4.007 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 6629 ; 5.003 ;29.227 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 6630 ; 5.002 ;29.228 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 10449 ; 2.457 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 402 ;31.451 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 10433 ;14.173 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 39 373 B 39 373 22828 0.06 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5N0F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1200003353. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92819 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS, XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 84827 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.690 REMARK 200 RESOLUTION RANGE LOW (A) : 52.320 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 7.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.69 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 8.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4D4D REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M AMMONIUM NITRATE, PH 6.5, 20% REMARK 280 PEG 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 42.52500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.82500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.20000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.82500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.52500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.20000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 14 REMARK 465 GLY A 15 REMARK 465 SER A 16 REMARK 465 SER A 17 REMARK 465 HIS A 18 REMARK 465 HIS A 19 REMARK 465 HIS A 20 REMARK 465 HIS A 21 REMARK 465 HIS A 22 REMARK 465 HIS A 23 REMARK 465 SER A 24 REMARK 465 SER A 25 REMARK 465 GLY A 26 REMARK 465 LEU A 27 REMARK 465 GLU A 28 REMARK 465 VAL A 29 REMARK 465 LEU A 30 REMARK 465 PHE A 31 REMARK 465 GLN A 32 REMARK 465 GLY A 33 REMARK 465 PRO A 34 REMARK 465 ALA A 35 REMARK 465 TYR A 36 REMARK 465 THR A 37 REMARK 465 ALA A 38 REMARK 465 GLN A 354 REMARK 465 LEU A 355 REMARK 465 LEU A 356 REMARK 465 SER A 357 REMARK 465 ILE A 375 REMARK 465 MET B 15 REMARK 465 GLY B 16 REMARK 465 SER B 17 REMARK 465 SER B 18 REMARK 465 SER B 24A REMARK 465 SER B 24B REMARK 465 GLY B 24C REMARK 465 LEU B 24D REMARK 465 GLU B 24E REMARK 465 VAL B 24F REMARK 465 LEU B 24G REMARK 465 PHE B 24H REMARK 465 GLN B 24I REMARK 465 GLY B 24J REMARK 465 PRO B 24K REMARK 465 ALA B 24L REMARK 465 TYR B 24M REMARK 465 THR B 24N REMARK 465 ALA B 24O REMARK 465 ILE B 375 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS B 24 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 266 OH TYR A 319 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 175 -81.19 -88.40 REMARK 500 HIS A 234 -58.02 -136.03 REMARK 500 PRO A 238 48.57 -85.40 REMARK 500 SER B 175 -81.85 -88.23 REMARK 500 HIS B 234 -60.12 -141.86 REMARK 500 PRO B 238 49.87 -88.85 REMARK 500 LEU B 279 40.77 -99.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 757 DISTANCE = 6.25 ANGSTROMS REMARK 525 HOH B 801 DISTANCE = 6.15 ANGSTROMS REMARK 525 HOH B 802 DISTANCE = 6.62 ANGSTROMS DBREF 5N0F A 35 375 UNP Q9Z4P9 Q9Z4P9_BACCI 35 375 DBREF 5N0F B 24L 375 UNP Q9Z4P9 Q9Z4P9_BACCI 35 375 SEQADV 5N0F MET A 14 UNP Q9Z4P9 INITIATING METHIONINE SEQADV 5N0F GLY A 15 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F SER A 16 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F SER A 17 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F HIS A 18 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F HIS A 19 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F HIS A 20 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F HIS A 21 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F HIS A 22 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F HIS A 23 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F SER A 24 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F SER A 25 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F GLY A 26 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F LEU A 27 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F GLU A 28 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F VAL A 29 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F LEU A 30 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F PHE A 31 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F GLN A 32 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F GLY A 33 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F PRO A 34 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F GLN A 341 UNP Q9Z4P9 ARG 341 ENGINEERED MUTATION SEQADV 5N0F MET B 15 UNP Q9Z4P9 INITIATING METHIONINE SEQADV 5N0F GLY B 16 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F SER B 17 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F SER B 18 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F HIS B 19 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F HIS B 20 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F HIS B 21 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F HIS B 22 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F HIS B 23 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F HIS B 24 UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F SER B 24A UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F SER B 24B UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F GLY B 24C UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F LEU B 24D UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F GLU B 24E UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F VAL B 24F UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F LEU B 24G UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F PHE B 24H UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F GLN B 24I UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F GLY B 24J UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F PRO B 24K UNP Q9Z4P9 EXPRESSION TAG SEQADV 5N0F GLN B 341 UNP Q9Z4P9 ARG 341 ENGINEERED MUTATION SEQRES 1 A 362 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 362 LEU GLU VAL LEU PHE GLN GLY PRO ALA TYR THR ALA SER SEQRES 3 A 362 ASP GLY ASP THR ALA MET LYS ALA PHE ASN ASP THR PHE SEQRES 4 A 362 TRP ASP PRO ASN ALA LYS MET PHE TRP LYS ASP SER LYS SEQRES 5 A 362 ARG GLU LYS HIS GLN ASP PHE TRP VAL GLU ALA GLU LEU SEQRES 6 A 362 TRP GLU LEU VAL MET ASP ALA TYR GLN HIS THR SER ASP SEQRES 7 A 362 PRO ALA LEU LYS ALA GLU LEU LYS THR GLN ILE ASP ASP SEQRES 8 A 362 VAL TYR ASP GLY THR VAL ALA LYS TYR GLY GLN ASP TRP SEQRES 9 A 362 THR ASN ASN PRO PHE ASN ASP ASP ILE MET TRP TRP ALA SEQRES 10 A 362 MET GLY SER ALA ARG ALA TYR GLN ILE THR GLY ASN PRO SEQRES 11 A 362 ARG TYR LEU GLU ALA ALA ARG ASP HIS PHE ASP PHE VAL SEQRES 12 A 362 TYR ASP THR GLN TRP ASP GLU GLU PHE ALA ASN GLY GLY SEQRES 13 A 362 ILE TRP TRP LEU ASN SER ASP HIS ASN THR LYS ASN ALA SEQRES 14 A 362 CYS ILE ASN PHE PRO ALA ALA GLN ALA ALA LEU TYR LEU SEQRES 15 A 362 TYR ASP ILE THR LYS ASP GLU HIS TYR LEU ASN ALA ALA SEQRES 16 A 362 THR LYS ILE PHE ARG TRP GLY LYS THR MET LEU THR ASP SEQRES 17 A 362 GLY ASN GLY LYS VAL PHE ASP ARG ILE GLU ILE GLU HIS SEQRES 18 A 362 GLY ALA VAL PRO ASP ALA THR HIS TYR ASN GLN GLY THR SEQRES 19 A 362 TYR ILE GLY SER ALA VAL GLY LEU TYR LYS ALA THR GLY SEQRES 20 A 362 ASN ALA VAL TYR LEU ASP ASP ALA VAL LYS ALA ALA LYS SEQRES 21 A 362 PHE THR LYS ASN HIS LEU VAL ASP SER ASN GLY VAL LEU SEQRES 22 A 362 ASN TYR GLU GLY PRO ASN GLY ASP LEU LYS GLY GLY LYS SEQRES 23 A 362 THR ILE LEU MET ARG ASN LEU ALA HIS LEU GLN LYS THR SEQRES 24 A 362 LEU ASP GLU THR GLY GLN TYR PRO GLU PHE SER ALA GLU SEQRES 25 A 362 PHE ASP GLU TRP LEU ALA PHE ASN ILE GLU MET ALA TRP SEQRES 26 A 362 SER HIS GLN ASN SER ASP HIS ILE VAL ASP GLY ASN TRP SEQRES 27 A 362 ALA GLY GLN LEU LEU SER GLY THR TYR GLU SER TRP SER SEQRES 28 A 362 SER ALA ALA ALA VAL GLN ALA LEU ASN GLY ILE SEQRES 1 B 362 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 362 LEU GLU VAL LEU PHE GLN GLY PRO ALA TYR THR ALA SER SEQRES 3 B 362 ASP GLY ASP THR ALA MET LYS ALA PHE ASN ASP THR PHE SEQRES 4 B 362 TRP ASP PRO ASN ALA LYS MET PHE TRP LYS ASP SER LYS SEQRES 5 B 362 ARG GLU LYS HIS GLN ASP PHE TRP VAL GLU ALA GLU LEU SEQRES 6 B 362 TRP GLU LEU VAL MET ASP ALA TYR GLN HIS THR SER ASP SEQRES 7 B 362 PRO ALA LEU LYS ALA GLU LEU LYS THR GLN ILE ASP ASP SEQRES 8 B 362 VAL TYR ASP GLY THR VAL ALA LYS TYR GLY GLN ASP TRP SEQRES 9 B 362 THR ASN ASN PRO PHE ASN ASP ASP ILE MET TRP TRP ALA SEQRES 10 B 362 MET GLY SER ALA ARG ALA TYR GLN ILE THR GLY ASN PRO SEQRES 11 B 362 ARG TYR LEU GLU ALA ALA ARG ASP HIS PHE ASP PHE VAL SEQRES 12 B 362 TYR ASP THR GLN TRP ASP GLU GLU PHE ALA ASN GLY GLY SEQRES 13 B 362 ILE TRP TRP LEU ASN SER ASP HIS ASN THR LYS ASN ALA SEQRES 14 B 362 CYS ILE ASN PHE PRO ALA ALA GLN ALA ALA LEU TYR LEU SEQRES 15 B 362 TYR ASP ILE THR LYS ASP GLU HIS TYR LEU ASN ALA ALA SEQRES 16 B 362 THR LYS ILE PHE ARG TRP GLY LYS THR MET LEU THR ASP SEQRES 17 B 362 GLY ASN GLY LYS VAL PHE ASP ARG ILE GLU ILE GLU HIS SEQRES 18 B 362 GLY ALA VAL PRO ASP ALA THR HIS TYR ASN GLN GLY THR SEQRES 19 B 362 TYR ILE GLY SER ALA VAL GLY LEU TYR LYS ALA THR GLY SEQRES 20 B 362 ASN ALA VAL TYR LEU ASP ASP ALA VAL LYS ALA ALA LYS SEQRES 21 B 362 PHE THR LYS ASN HIS LEU VAL ASP SER ASN GLY VAL LEU SEQRES 22 B 362 ASN TYR GLU GLY PRO ASN GLY ASP LEU LYS GLY GLY LYS SEQRES 23 B 362 THR ILE LEU MET ARG ASN LEU ALA HIS LEU GLN LYS THR SEQRES 24 B 362 LEU ASP GLU THR GLY GLN TYR PRO GLU PHE SER ALA GLU SEQRES 25 B 362 PHE ASP GLU TRP LEU ALA PHE ASN ILE GLU MET ALA TRP SEQRES 26 B 362 SER HIS GLN ASN SER ASP HIS ILE VAL ASP GLY ASN TRP SEQRES 27 B 362 ALA GLY GLN LEU LEU SER GLY THR TYR GLU SER TRP SER SEQRES 28 B 362 SER ALA ALA ALA VAL GLN ALA LEU ASN GLY ILE HET 7K2 A 401 21 HET 7K2 B 401 21 HETNAM 7K2 [(3S,4R,5R)-4,5-DIHYDROXYPIPERIDIN-3-YL]METHYL 1-THIO- HETNAM 2 7K2 ALPHA-D-MANNOPYRANOSIDE HETSYN 7K2 (2~{R},3~{S},4~{S},5~{S},6~{R})-2-[[(3~{S},4~{R}, HETSYN 2 7K2 5~{R})-4,5-BIS(OXIDANYL)PIPERIDIN-3- HETSYN 3 7K2 YL]METHYLSULFANYL]-6-(HYDROXYMETHY L)OXANE-3,4,5- HETSYN 4 7K2 TRIOL; ISOFAGOMINE-THIOL-ALPHA-D-MANNOPYRANOSIDE; HETSYN 5 7K2 [(3S,4R,5R)-4,5-DIHYDROXYPIPERIDIN-3-YL]METHYL 1-THIO- HETSYN 6 7K2 ALPHA-D-MANNOSIDE; [(3S,4R,5R)-4,5-DIHYDROXYPIPERIDIN- HETSYN 7 7K2 3-YL]METHYL 1-THIO-D-MANNOSIDE; [(3S,4R,5R)-4,5- HETSYN 8 7K2 DIHYDROXYPIPERIDIN-3-YL]METHYL 1-THIO-MANNOSIDE FORMUL 3 7K2 2(C12 H23 N O7 S) FORMUL 5 HOH *559(H2 O) HELIX 1 AA1 SER A 39 PHE A 52 1 14 HELIX 2 AA2 ASP A 71 THR A 89 1 19 HELIX 3 AA3 ASP A 91 GLY A 114 1 24 HELIX 4 AA4 PHE A 122 GLY A 141 1 20 HELIX 5 AA5 ASN A 142 TRP A 161 1 20 HELIX 6 AA6 GLU A 164 GLY A 168 5 5 HELIX 7 AA7 ALA A 182 LYS A 200 1 19 HELIX 8 AA8 ASP A 201 LEU A 219 1 19 HELIX 9 AA9 THR A 241 GLY A 260 1 20 HELIX 10 AB1 ALA A 262 LEU A 279 1 18 HELIX 11 AB2 GLY A 298 GLY A 317 1 20 HELIX 12 AB3 TYR A 319 SER A 339 1 21 HELIX 13 AB4 GLU A 361 ASN A 373 1 13 HELIX 14 AB5 ASP B 40 PHE B 52 1 13 HELIX 15 AB6 ASP B 71 THR B 89 1 19 HELIX 16 AB7 ASP B 91 GLY B 114 1 24 HELIX 17 AB8 PHE B 122 GLY B 141 1 20 HELIX 18 AB9 ASN B 142 TRP B 161 1 20 HELIX 19 AC1 ALA B 182 LYS B 200 1 19 HELIX 20 AC2 ASP B 201 LEU B 219 1 19 HELIX 21 AC3 THR B 241 GLY B 260 1 20 HELIX 22 AC4 ASN B 261 LEU B 279 1 19 HELIX 23 AC5 GLY B 298 GLY B 317 1 20 HELIX 24 AC6 TYR B 319 HIS B 340 1 22 HELIX 25 AC7 GLU B 361 ASN B 373 1 13 SHEET 1 AA1 2 TRP A 53 ASP A 54 0 SHEET 2 AA1 2 MET A 59 PHE A 60 -1 O MET A 59 N ASP A 54 SHEET 1 AA2 2 THR A 179 ASN A 181 0 SHEET 2 AA2 2 ARG A 229 GLU A 231 -1 O ILE A 230 N LYS A 180 SHEET 1 AA3 2 TRP B 53 ASP B 54 0 SHEET 2 AA3 2 MET B 59 PHE B 60 -1 O MET B 59 N ASP B 54 SHEET 1 AA4 2 THR B 179 ASN B 181 0 SHEET 2 AA4 2 ARG B 229 GLU B 231 -1 O ILE B 230 N LYS B 180 CISPEP 1 GLY A 290 PRO A 291 0 11.73 CISPEP 2 GLY B 290 PRO B 291 0 10.48 CRYST1 85.050 86.400 103.650 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011758 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011574 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009648 0.00000